Purchase Order 75H71225P00090

Award Date 2/24/25
Potential Completion Date 6/18/28
Potential Value $40K
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Winterhaven, CA 92283, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service. The contract, with a ceiling value of $500,000.00, is a Blanket Purchase Agreement (BPA) call that will provide the agency with Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products will be used to detect infectious diseases such as COVID-19, influenza, RSV, MRSA, and sexually transmitted...
This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, is a delivery order valued at $196,959.10. The contract is with the Indian Health Service, a civilian agency under the Department of Health and Human Services. Cepheid will provide the agency with CEPHEID SUPPLIES, which includes GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza,...
This is a firm fixed-price purchase order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for a CEPHEID SERVICE AGREEMENT to reinstate service and provide a base year plus three option years, with a ceiling value of $32,600.00. The contract supports the Indian Health Service's clinical testing programs by providing Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, worth up to $170,000.00, was awarded by the Department of Health and Human Services Indian Health Service. The contract is a delivery order and is a firm fixed-price contract type. The contract is not set aside. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms...
This federal contract award is for the provision of laboratory supplies and testing services related to the Cepheid Diagnostic System. The contract was awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service, a civilian agency of the U.S. government. The contract has a ceiling value of $313,925.00 and a performance period from September 1, 2024 to August 31, 2025, with an ultimate completion date of August 31, 2028. The contract is a delivery...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and others. The contract, valued at $2,040.00, is a firm fixed-price delivery order placed by the Defense Logistics Agency, a defense agency. The contract does not have a set-aside...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of in vitro diagnostic substances, reagents, test kits, and sets. The contract, valued at $152,180.19, was issued by the Department of Health and Human Services Indian Health Service and does not have a set-aside designation. Cepheid, the prime contractor, supplies a range of goods and services related to diagnostic testing equipment, reagents, and consumables, as well as...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of COVID-19 test kits to the Department of Health and Human Services Indian Health Service. The firm fixed-price contract has a potential value of $173,730.00 and is set to be completed by April 5, 2023. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the Indian Health...
This federal contract award is for Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID 4PLEX+ COVID-19 TESTING KITS to the Indian Health Service (IHS). The award, valued at $402,084.00, is a firm fixed-price delivery order placed under an existing Indefinite Delivery Contract. The contract has no set-aside designation. Cepheid has previously received various federal contract awards and grants, including Blanket Purchase Agreements with the Department of...
This is a delivery order (contract number 75H71121F27013) awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $81,600.00 and was awarded on August 6, 2021 with a completion date of July 27, 2022. It is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle (number 75H70420D00001) awarded to Cepheid...

This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, is for a Service Agreement valued at $39,679.43. The contract has an ultimate completion date of June 18, 2028 and was awarded on February 24, 2025 by the Indian Health Service, a civilian federal agency. The contract is a firm fixed-price purchase order and does not have a set-aside designation.

The contract provides for the supply of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of various infectious diseases, including COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. Cepheid has previously held several significant federal contract Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and Indian Health Service, enabling these agencies to continuously procure Cepheid's molecular diagnostic solutions.

Generated 5/17/25, 9:51 AM